Industry News- Changzhou Zhiyang Machinery Equipment Co., Ltd.

Industry News

On most oral solid dosage lines, the biggest source of powder exposure and batch-to-batch variability is not the granul...

Aug 28, 2026

Industry News

At the end of a production shift, a thin film of active residue might remain inside a high-shear granulator. It is invi...

Aug 19, 2026

Industry News

A tablet that performs flawlessly at laboratory scale does not always survive the move to commercial production. In mos...

Aug 14, 2026

Industry News

Your development team has just received the toxicology report for a new oncology API. The occupational exposure limit (...

Aug 07, 2026

Industry News

What is Amorphous Spray Dried Dispersion (ASDD)? Over 70% of new drug candidates fall into BCS Class II or IV — high pe...

Jul 27, 2026

Industry News

In a typical oral solid dose, the active pharmaceutical ingredient (API) may constitute less than 2% of the total tablet...

Jul 22, 2026

Industry News

What Are Pharmaceutical Containment Solutions? In 2026, over 30% of drugs in development are classified as potent or hi...

Jul 15, 2026

Industry News

What Is Fluid Bed Granulation? A single batch of powder can move from blending to dried granules in under 90 minutes — ...

Jul 08, 2026

Industry News

A single failed cleaning validation run can freeze an entire oral solid dosage line for weeks. The investigation rarely...

Jun 29, 2026

Industry News

Understanding the Root Causes of Tablet Defects A single capping defect can trigger a full batch rejection, costing $50...

Jun 23, 2026

Industry News

1. Defining the Design Basis: Product, Scale, and Regulatory Target A project team once spent eight months on a facilit...

Jun 16, 2026

Industry News

In 2026, over 70% of oncology pipeline candidates are classified as high potent APIs (HPAPIs) — compounds with an occup...

Jun 10, 2026